Cystic Fibrosis Weekly Update

Contents:

Translate Bio Advancing MRT5005 Through Ongoing Phase 1/2 Trial in CF Patients

Mar 06, 2019 07:00 am | Alice Melão

An ongoing Phase 1/2 clinical trial exploring Translate Bio’s investigational therapy MRT5005 will start testing multiple ascending doses (MAD) in patients with cystic fibrosis (CF). This follows an assessment by a protocol review safety committee, which reviewed the study’s protocol and interim safety data. The committee approved the continuation of the trial as planned, allowing […]
The post Translate Bio Advancing MRT5005 Through Ongoing Phase 1/2 Trial in CF Patientsappeared first on Cystic Fibrosis News Today.

MaRS Innovation Supports LAB150 Research on New Therapeutics for CF and Other Conditions

Mar 05, 2019 10:00 am | Vijaya Iyer

MaRS Innovation recently announced the launch of two new projects targeting the development of new therapeutics for cystic fibrosis (CF) and respiratory syncytial virus (RSV). These projects are part of LAB150, MaRS Innovation’s joint venture with Evotec AG to support collaboration among scientists, investors, and pharmaceutical companies to accelerate development of new therapies. “We are thrilled to be […]
The post MaRS Innovation Supports LAB150 Research on New Therapeutics for CF and Other Conditions appeared first on Cystic Fibrosis News Today.

Don’t Distance Yourself from Your OG Carers

Mar 05, 2019 09:00 am | Brad Dell

We sat in pristine sands shadowed by titanic sentries dubbed The Twelve Apostles. At the southern end of Australia, I assume they guard against Antarctic penguins, like how The Wall in “Game of Thrones” defended against White Walkers. Maybe an invasion of penguins wouldn’t be bad. “I can’t believe we’re here,” whispered Josh in worship […]
The post Don’t Distance Yourself from Your OG Carers appeared first on Cystic Fibrosis News Today.